CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)

被引:0
作者
Popat, Rakesh [1 ]
Wilson, William [2 ]
Camilleri, Marquita [2 ,3 ]
De Tute, Ruth
Pang, Gavin [2 ]
Jenner, Richard [2 ]
Dadaga, Tushhar [2 ]
Kamora, Sumaiya [2 ]
Streetly, Matthew [4 ]
Ramasamy, Karthik [5 ]
Phillips, Elizabeth [6 ]
Chapman, Mike [7 ]
Bygrave, Ceri [8 ]
Cavenagh, James [9 ]
Sive, Jonathan [2 ,10 ]
Benjamin, Reuben
Eccersley, Lydia [9 ]
Hassan, Sandra [11 ]
Willis, Fenella [12 ]
Clifton-Hadley, Laura [13 ]
Owen, Roger [14 ]
Yong, Kwee [2 ]
机构
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
[2] UCL, Canc Res UK & UCL Canc Trials Ctr, London, England
[3] St James Hosp Leeds, HMDS, Leeds, W Yorkshire, England
[4] Guys & St Thomas NHS Trust, Leeds, W Yorkshire, England
[5] Univ Oxford, Hosp NHS Trust, Oxford, England
[6] Christie NHS Fdn Trust, Manchester, Lancs, England
[7] Cambridge Inst Med Res, Cambridge, England
[8] Univ Hosp Wales, London, England
[9] Barts Hlth NHS Trust, London, England
[10] Kings Coll Hosp London, London, England
[11] Queens Hosp, London, England
[12] St Georges NHS Trust, London, England
[13] UCL, Canc Res UK & UCL Canc Trials Ctr, London, England
[14] St James Inst Oncol, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OAB-003
引用
收藏
页码:S2 / S3
页数:2
相关论文
共 50 条
[31]   Geriatric assessment (GA) and eligibility for autologous stem cell transplant (ASCT) in older adults with newly diagnosed multiple myeloma (MM). [J].
Wildes, Tanya Marya ;
Tuchman, Sascha Alexander ;
Depp, Brittany ;
Chen, Ling ;
Stockerl-Goldstein, Keith ;
Vij, Ravi ;
Colditz, Graham A. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[32]   A PHASE I/II TRIAL OF CYCLOPHOSPHAMIDE, CARFILZOMIB, THALIDOMIDE AND DEXAMETHASONE (CYCLONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA [J].
Mikhael, J. ;
Reeder, C. ;
Libby, E. ;
Costa, L. ;
Mayo, A. ;
Bergsagel, L. ;
Buadi, F. ;
Pirooz, N. ;
Lubben, J. ;
Dueck, A. ;
Stewart, A. .
HAEMATOLOGICA, 2012, 97 :119-119
[33]   Maintenance with Carfilzomib Following Carfilzomib, Cyclophosphamide and Dexamethasone at First Relapse or Primary Refractory Multiple Myeloma (MM) on the Phase 2 Muk Five Study: Effect on Minimal Residual Disease [J].
Yong, Kwee ;
Hinsley, Samantha ;
De Tute, Ruth M. ;
Sherratt, Debbie ;
Brown, Sarah R. ;
Flanagan, Louise ;
Williams, Catherine ;
Cavenagh, Jamie ;
Kaiser, Martin ;
Rabin, Neil K. ;
Ramasamy, Karthik ;
Garg, Mamta ;
Auner, Holger W. ;
Morgan, Gareth ;
Davies, Faith E. ;
Owen, Roger G. .
BLOOD, 2018, 132
[34]   Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group [J].
Gregersen, Henrik ;
Peceliunas, Valdas ;
Remes, Kari ;
Schjesvold, Fredrik ;
Abildgaard, Niels ;
Nahi, Hareth ;
Andersen, Niels Frost ;
Vangsted, Annette Juul ;
Klausen, Tobias Wirenfeldt ;
Helleberg, Carsten ;
Carlson, Kristina ;
Frolund, Ulf Christian ;
Axelsson, Per ;
Stromberg, Olga ;
Blimark, Cecilie Hveding ;
Crafoord, Jacob ;
Tsykunova, Galina ;
Eshoj, Henrik Rode ;
Waage, Anders ;
Hansson, Markus ;
Gulbrandsen, Nina .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 108 (01) :34-44
[35]   CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CCD) FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: INITIAL RESULTS OF A MULTICENTER, OPEN LABEL PHASE II STUDY [J].
Bringhen, S. ;
Federica, C. ;
Petrucci, M. ;
Gay, F. ;
Federico, V. ;
Conticello, C. ;
Pantani, L. ;
Montefusco, V. ;
Benevolo, G. ;
Aschero, S. ;
Offidani, M. ;
Villani, O. ;
Siniscalchi, A. ;
Rossi, D. ;
Magarotto, V. ;
Sonneveld, P. ;
Boccadoro, M. ;
Palumbo, A. .
HAEMATOLOGICA, 2013, 98 :242-242
[36]   INITIAL RESULTS FROM A PHASE 2 STUDY OF CARFILZOMIB, LENALIDOMIDE, AND LOW-DOSE DEXAMETHASONE (KRD) PLUS AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) [J].
Zimmerman, T. M. ;
Griffith, K. ;
Jasielec, J. K. ;
Rosenbaum, C. A. ;
McDonnell, K. ;
Marin, J. ;
Bakker, J. ;
Berdeja, J. G. ;
Vij, R. ;
Jakubowiak, A. J. .
HAEMATOLOGICA, 2014, 99 :103-103
[37]   Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM). [J].
Murthy, A ;
Gojo, I ;
Fassas, A ;
Tricot, G ;
Fenton, R ;
Mookerjee, B ;
Meisenberg, B ;
Takebe, N ;
Lipani, T ;
Badros, A ;
Phillips, G ;
Sarkodee-Adoo, C ;
Heyman, M ;
Ruehle, K ;
Smith, R ;
Guo, CF ;
Rapoport, A .
BLOOD, 2001, 98 (11) :685A-685A
[38]   Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM). [J].
Gojo, I ;
Murthy, A ;
Fassas, A ;
Tricot, G ;
Fenton, R ;
Mookerjee, B ;
Meisenberg, B ;
Takebe, N ;
Frankel, SR ;
Sarkodee-Adoo, C ;
Heyman, MR ;
Ruehle, K ;
Smith, R ;
Chen, T ;
Rapoport, A .
BLOOD, 2000, 96 (11) :369B-369B
[39]   Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM) [J].
Nooka, Ajay K. ;
Langston, Amelia A. ;
Waller, Edmund K. ;
Heffner, Leonard T. ;
Gleason, Charise ;
Muppidi, Samatha ;
Watson, Melanie ;
Casbourne, Daniela ;
Boise, Lawrence ;
Kaufman, Jonathan L. ;
Lonial, Sagar .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[40]   Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCyd) in Elderly Newly Diagnosed Multiple Myeloma Patients: Results of a Phase 2 Study [J].
Bringhen, Sara ;
Rossi, Davide ;
Larocca, Alessandra ;
Corradini, Paolo ;
Galieni, Piero ;
Malfitano, Alessandra ;
Aschero, Simona ;
Offidani, Massimo ;
Liberati, Anna Marina ;
Genuardi, Mariella ;
Gaidano, Gianluca ;
Palladino, Carmela ;
Gentilini, Fabiana ;
Boccadoro, Mario ;
Sonneveld, Pieter ;
Palumbo, Antonio .
BLOOD, 2015, 126 (23)